Preconception care for women with pre-existing
medical diseases
Sue ST Lo 羅善清
HK Pract 2023;45:4-8
Summary
Preconception care is defined as the provision of
biomedical, behavioural, and social health interventions
to women and couples before conception occurs. It is
about embedding principles and actions into current
care models prior to first and subsequent pregnancies,
and its objective is to improve couple’s health during
their life course, minimise obstetric risks and optimise
the development of their foetuses. This article illustrates
how family physicians can provide preconception care
and advice during their usual care for women with pre-existing
medical diseases.
Keywords:
Obesity, Family physicians, Primary care
摘要
孕前保健是指在婦女懷孕前向她及其伴侶提供身心、行
為和生活的改善建議, 以達致提升健康, 減低孕期風
險,及優化胎兒發育的目標。本文解構了家庭醫生如何
把孕前保健融入日常的診症中,為有基礎病的婦女提供
適切的孕前準備建議。
關鍵詞:
肥胖,家庭醫生,基層醫療
Introduction
Giving every child the best start in life is the
priority of every parent. This is particularly important
for women with pre-existing medical diseases because
maternal and foetal wellbeing can be compromised
by their illness and drug treatment. According to the
service statistics of the Family Planning Association
of Hong Kong (FPAHK), the top five pre-existing
medical diseases among women attending their
Prepregnancy Preparation Service are (in order) thyroid
diseases, depression, asthma, epilepsy, and systemic
lupus erythematosus (SLE). Preconception care aims
at minimising maternal morbidity and optimising the
epigenetic environment for the developing foetus. There
is evidence to support preconception interventions
improve maternal and neonatal outcomes.1
Preconception care is different for each person.
This is a person-centred, holistic care that helps
women plan their best time to conceive, optimise
their fitness for pregnancy, live well and stay healthy.
Family physicians have a key role in assisting couples
to identify preconception risks and help them make
informed decisions about planning or avoiding
pregnancy. No one expects an unplanned pregnancy,
but it happens often. If a family physician determines
that pregnancy is risky for a woman with a pre-existing
medical disease because the disease is poorly controlled
or a potentially teratogenic drug cannot be suspended,
effective contraceptives should be provided to avoid an
unplanned pregnancy.
Planning pregnancy
The median age of first childbirth in local women
has steadily increased from 28.1 to 32.6 years old
between 1991 and 2021.2 Therefore, the demand for
infertility treatment and high-risk obstetric care required
by older moms will not abate in the near future. To
reduce such burden on the public healthcare system,
couples should be encouraged to plan parenthood once
they get married. They need to decide on the number
of children they want, the timing of conception, the
spacing of pregnancies and which contraceptive to use.
Women with pre-existing medical diseases should be
informed about the effect of their diseases and treatment
on pregnancy and the developing foetus, and vice versa.
Controlling medical illness
For women with pre-existing medical illness,
choosing the best time to conceive is particularly
important. As a general rule, the best time to conceive is
the time when the disease is in remission, or when it is well-controlled with medications which are compatible
with pregnancy. Uncontrolled diseases can increase
risk of medical as well as obstetric complications and
compromise foetal development. This is particularly
important for diseases like SLE, hyperthyroidism and type
1 or 2 diabetes mellitus. A systematic review and metaanalysis
of observational studies of preconception care
for women with pre-existing diabetes has demonstrated
that receiving such care resulted in lower maternal
HbA1c levels during their first trimester and a reduction
in congenital malformations, preterm delivery, perinatal
mortality, and neonatal intensive care unit admission.3
The glycaemic target suggested by the American
Diabetes Association is HbA1c <6.5%, to reduce
the risk of congenital malformations, preeclampsia,
macrosomia, preterm birth, and other complications.4
Adjusting medications
When a family physician treats reproductive age
women, one should always be aware of the possibility
of pregnancy and avoid teratogenic drugs. When no
alternatives are available, teratogenic drugs such as
isotretinoin, valproate and phenytoin can be used if the
benefits of treatment outweigh the risks. These women
need to understand the teratogenicity of the treatment
and agree to use highly effective contraceptives.5
Patients should be encouraged to discuss the timing of
their pregnancy so that the family physician can try to
stabilise their disease with less teratogenic drugs before
they conceive. For the treatment of hyperthyroidism,
propylthiouracil should be used instead of carbimazole.
SLE patients should stop mycophenolate mofetil,
cyclophosphamide, methotrexate, and thalidomide at
least three months before contemplating pregnancy.6
Serotonin-norepinephrine reuptake inhibitors (SNRIs)
like venlafaxine (Effexor) are associated with more
birth defects than selective serotonin reuptake inhibitors
(SSRIs) like sertraline (Zoloft), fluoxetine (Prozac) and
paroxetine (Paxil). Escitalopram (Lexapro) is the SSRI
with the lowest number of birth defects reported.7 Choice
of antidepressant is based on shared decision making with
your patients, taking into account the safety, effectiveness,
differences in disease severity, relapse risk and the
patient’s experience, etc. There is no single best drug.
Detailed information regarding teratogenic drugs
or drugs with potential teratogenic effects is available
from the UK teratogenic information service website
(www.uktis.org). The US Centers for Disease Control and Prevention (CDC) Treating for Two Initiative
(https://www.cdc.gov/pregnancy/meds/treatingfortwo/
index.html) also provides useful guidelines and
recommendations in helping physicians and women
identify the safest treatment options for common
conditions before, during, and after pregnancy
Vaccination
Congenital rubella syndrome, influenza, and
hepatitis B infection are all vaccine-preventable
diseases which can lead to poor maternal and neonatal
outcomes.8 Although the rubella vaccination has been
included in the local childhood immunisation program
since 1978, 5.5% of women attending the FPAHK
Premarital Check-up and Prepregnancy Preparation
Services tested negative for the rubella antibody in
2021. In these cases, non-immunise women are offered
immunisation and are reminded to avoid becoming
pregnant until one month after vaccination.9
Women contemplating pregnancy should also
consider vaccination against COVID-19 and seasonal
flu. Hepatitis B vaccination should be provided to non-immunise
women who work in the healthcare sector
or whose partner is a carrier. According to the CDC,
COVID-19 and hepatitis B vaccination started before
pregnancy can be safely completed even if the woman
gets pregnant subsequently.
Fitness for pregnancy
Unhealthy behaviours are usually established well
before pregnancy, thus early intervention at the start of
reproductive years could help to mitigate preconception
risks, promote fitness for pregnancy, and improve
overall health and wellbeing. A universal, life-course
approach helps women adopt healthy lifestyle choices
such as having a balanced diet, regular exercise, and
maintaining emotional wellbeing. These lifestyle
modifications not only promote fitness for pregnancy
but are also important adjuncts to disease management
in women with chronic illness.
Diet
Local studies had shown inadequate dietary intake
of iodine10,11, Vitamin D12, fibre, calcium and iron13
among reproductive age women. The FIGO Nutrition
Checklist14 is a validated clinical practice tool that
assists physicians in collecting baseline information
on pre-pregnant weight and nutritional status and identifying nutritional issues that require attention. The
checklist on the front page consists of four sections,
with questions on specific dietary requirements,
body mass index, diet quality and micronutrients. On
the back page, there are guidance notes to aid the
physician in interpreting the responses and providing
counselling. Using this Checklist, Tsoi et al found that
95% of healthy pregnant women in early pregnancy
recruited at their first antenatal visit reported at least
one out of six suboptimal dietary practices.15 There was
ample evidence to support the importance of maternal
nutrition on long-term non-communicable disease
risk for mothers as well as for future generations.14,16
Supplementation
There is conclusive evidence that periconceptional
folic acid supplementation prevents the first occurrence17
and recurrence18 of neural tube defects (NTD). For
women at low risk, they should start 0.4mg folic acid
daily 2-3 months before conception and continued to 12
weeks’ gestation.19,20 For high-risk women, i.e. those who
had previous affected babies and those on anti-epileptic
drugs, the American College of Obstetricians and
Gynecologists19 recommends 4mg folic acid daily while
the Royal College of Obstetricians and Gynaecologists
(RCOG) 20 recommends 5mg. The RCOG also
recommends 5mg folic acid daily for women or partners
who have NTD, women who have celiac disease, diabetes
mellitus and those with BMI ≥30kg/m2.20 In Hong
Kong, only 5mg folic acid tablets are available (https://
www.drugoffice.gov.hk/eps/do/en/doc/Compdium.pdf).
Targeted supplementation should be given to meet
specific needs of individual women. Complete blood
count is usually taken for preconception assessment
and those with iron deficiency anaemia should be given
iron supplementation. Correction of anaemia before
pregnancy and in the first trimester reduces the risk
of preterm delivery and low birth weight babies.21 The
Department of Health recommends educating women on
adequate iodine intake during preconception to ensure
optimal maternal thyroid function to support thyroid and
neurodevelopment in the fetus.10 Women without thyroid
disease, who do not consume adequate iodine from
food to meet the daily requirement of 250μg should
consider iodine supplementation during pregnancy and
lactation.10 To date, no observational studies with large
sample size or randomised controlled trials have been
published on preconception iodine status or effect of iodine supplementation. In women with pre-existing
thyroid diseases, excessive iodine supplementation
may worsen their diseases. Other dietary or vitamin
supplementations have not been shown to improve
maternal or foetal outcomes.20
Weight optimisation
Weight optimisation is important before pregnancy
because overweight and obese women experienced
an increased risk of miscarriage, gestational diabetes,
gestational hypertension, preeclampsia, and caesarean
delivery compared to normal weight women.22,23
Besides, babies born to overweight and obese mothers
were at an increased risk of being admitted into
the neonatal intensive care unit, macrosomia, and
stillbirth.24 One study showed a 10% reduction in
preconception BMI in overweight and obese women
reduced the risk of gestational diabetes, preeclampsia,
large for gestational age, an APGAR score below 6 at 5
minutes, and admission of both mother and baby to the
intensive care unit by 15%.25 On the other hand, being
underweight during the preconception period increases
the risk of infertility, miscarriage, preterm birth, and
small for gestational age babies.26-28 Therefore, helping
women optimise their weight before pregnancy not only
improves their fertility potential, it can also improve
their maternal and perinatal outcomes.
Exercise
Women without contraindications (e.g. pre-existing
cardiopulmonary diseases, antepartum haemorrhage,
pre-eclampsia) should maintain an active life before,
during and after pregnancy. Any forms of mild to
moderate intensity aerobic exercises such as swimming,
brisk walking, stationary bicycling, modified Yoga and
modified Pilates improves heart-lung function, boost
mood and prevent overweight. Avoid exercises that
can cause injury such as contact sports, skydiving, hot
Yoga, hot Pilates, scuba diving, skiing, surfing, etc.
Avoid risk factors
Prepregnancy risk factors include smoking,
alcohol, and substance abuse. Family physicians should
encourage women to stop or avoid such behaviours
before they conceive. Foetal alcohol spectrum disorders
are a group of physical, behavioural, and learning
problems that can occur in a person who was exposed
to alcohol before birth. There is no known safe amount
of alcohol use before or during pregnancy. All types of alcoholic beverages are harmful, including beer and
wines. Cigarette smoking reduces fertility in both men
and women.29 Although smoking is not teratogenic, it
increases the risk of placenta previa, abruptio placentae,
intrauterine growth retardation, low birth weight, and
perinatal mortality.29 Therefore, men and women who
plan to conceive should stop smoking.
According to the 2021 data from the Central
Registry of Drug Abuse, heroin, methylamphetamine
(ice), and ketamine were the top three illicit drugs used
by females aged 21 and over in Hong Kong (https://www.nd.gov.hk/statistics_list/doc/en/t15.pdf). The use of illicit
drugs is associated with pregnancy complications, low
birth weight, infant mortality, and neonatal abstinence
syndrome.30 Any woman of a reproductive age who is
using illicit drugs should be referred to drug rehabilitation
programs for treatment and encouraged to use reliable
contraception to prevent any unplanned pregnancy.
Prevent foetal anomaly
With the advancement in genomic sequencing,
carrier screening can be offered to individuals or
couples to screen for over 100 types of autosomal
recessive or X-linked genetic disorders regardless of
ancestry and geographic origin. Preconception screening
is recommended over prenatal screening since it may be
less stressful on individuals who are tested positive.31
If both partners are found to be carriers of a genetic
condition, they should be referred to clinical geneticists
for counselling on their risk of having an affected child
and their reproductive options such as donor sperm /
egg, preimplantation genetic diagnosis with implantation
of only unaffected embryos, prenatal diagnosis during
pregnancy, adoption or remaining childless. In a local
study of 123 Chinese women who underwent carrier
screening, 56.1% of them were found to be carriers
of at least one disease and 47.6% were carriers after
excluding thalassaemias. The five most common
diseases found were GJB2-related DFNB1 nonsyndromic
hearing loss and deafness (1 in 4), alpha-thalassaemia
(1 in 7), 21-hydroxylase deficient congenital adrenal
hyperplasia (1 in 13), beta-thalassaemia (1 in 14), and
Pendred's syndrome (1 in 36).32
Conclusion
Family physicians play a key role in delivering
preconception care to women with pre-existing
medical diseases. They should be aware that women of
reproductive age can be pregnant at any time, hence they
should warn women against pregnancy when their disease
is not under control, avoid teratogenic investigations and
treatment if possible, and regularly review the women’s
lifestyle. Encouraging women to adopt “clean and healthy
living” during the preconception period helps to optimise
maternal and foetal outcomes.
References
-
Johnson K, Posner S, Biermann J, et al. Recommendations to improve
preconception health and health care—United States. A Report of the
CDC/ATSDR Preconception Care Work Group and the Select Panel on
Preconception Care. Morb Mortal Wkly Rep. 2006;55(RR06):1- 23.
-
Census and Statistics Department. Women and Men in Hong Kong. Key
statistics. 2022 edition. Hong Kong Special Administrative Region, China.
Available at: https://www.censtatd.gov.hk/en/data/stat_report/product/
B1130303/att/B11303032022AN22B0100.pdf (Accessed on 27 Oct 2022)
-
Wahabi HA, Fayed A, Esmaeil S, et al. Systematic review and meta-analysis
of the effectiveness of pre-pregnancy care for women with diabetes for
improving maternal and perinatal outcomes. PLoS One. 2020;15:e0237571.
-
American Diabetes Association Professional Practice Committee. Management
of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022.
Diabetes Care. 2022;45(Supplement_1):S232–S243.
-
Faculty of Sexual and Reproductive Healthcare. Clinical Effective Unit
Statement: Contraception for women using known teratogenic drugs or drugs
with potential teratogenic effects (February 2018). Available at: https://www.fsrh.org/documents/fsrh-ceu-statement-contraception-for-women-using-known/
(Accessed on 27 Oct 2022)
-
Bermas BL, Smith NA. Pregnancy in women with systemic lupus erythematosus.
UpToDate. Mar 25, 2021.
-
Anderson KN, Lind JN, Simeone RM, et al. Maternal Use of Specific
Antidepressant Medications During Early Pregnancy and the Risk of Selected
Birth Defects. JAMA Psychiatry. 2020;77(12):1246-1255.
-
Seshadri S, Oakeshott P, Nelson-Piercy C, et al. Prepregnancy care. BMJ.
2012 May 31;344:e3467.
-
Centers for Disease Control and Prevention. Vaccines Before Pregnancy. Page
last reviewed: November 9, 2021. Available at: https://www.cdc.gov/vaccines/pregnancy/vacc-before.html (Accessed on 27 Oct 2022)
-
Non-Communicable Disease Branch, Centre for Health Protection,
Department of Health. Iodine Survey Report 2021. https://www.chp.gov.hk/files/pdf/iodine_survey_report_en.pdf (Accessed on 27 Oct 2022)
-
Tam WH, Chan RS, Chan MH, et al. Moderate iodine deficiency among
pregnant women in Hong Kong: Revisit the problem after two decades. Hong Kong Med J. 2017;23:586–593.
-
Woo J, Lam CW, Leung J, et al. Very high rates of vitamin D insufficiency
in women of child-bearing age living in Beijing and Hong Kong. Br J Nutr.
2008;99:1330–1334.
-
Tsoi KY, Chan RSM, Tam CHT, et al. Dietary patterns of Chinese pregnant
women in Hong Kong. Asia Pac J Clin Nutr. 2022;31:378-393.
-
Hanson MA, Bardsley A, De-Regil LM, et al. The International Federation
of Gynecology and Obstetrics (FIGO) recommendations on adolescent,
preconception, and maternal nutrition: “Think Nutrition First”. Int J Gynecol
Obstet. 2015;131(Suppl.4):S213–S253.
-
Tsoi KY, Chan RSM, Li LS, et al. Evaluation of dietary pattern in early
pregnancy using the FIGO Nutrition Checklist compared to a food frequency
questionnaire. Int J Gynecol Obstet. 2020;151(Suppl. 1):37–44.
-
World Health Organization Regional Office for Europe. Good Maternal
Nutrition: The best start in life. Denmark: World Health Organization; 2016.Available at: https://www.euro.who.int/__data/assets/pdf_file/0008/313667/Good-maternal-nutrition-The-best-start-in-life.pdf (Accessed on 27 Oct 2022)
-
Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by
periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832–1835.
-
MRC Vitamin Study Research Group. Prevention of neural tube
defects: results of the Medical Research Council Vitamin Study. Lancet.
1991;338:131–137.
-
American College of Obstetricians and Gynecologists. ACOG practice
bulletin No. 187. Neural tube defects. Obstet Gynecol. 2017;130:e279 – e290.
-
Royal College of Obstetricians and Gynaecologists. Healthy eating and
vitamin supplements in pregnancy patient information leaflet. Available at:
https://www.rcog.org.uk/for-the-public/browse-all-patient-information-leaflets/healthy-eating-and-vitamin-supplements-in-pregnancy-patient-information-leaflet/
(Accessed on 27 Oct 2022)
-
FIGO Working Group on Good Clinical Practice in Maternal-Fetal Medicine.
Good clinical practice advice: Micronutrients in the periconceptional period
and pregnancy. Int J Gynaecol Obstet. 2019;144:317-321.
-
Magnus MC, Hockey RL, Håberg SE, et al. Pre-pregnancy lifestyle
characteristics and risk of miscarriage: the Australian Longitudinal Study on
Women's Health. BMC Pregnancy Childbirth. 2022;22:169.
-
Chen CN, Chen HS, Hsu HC. Maternal Prepregnancy Body Mass Index,
Gestational Weight Gain, and Risk of Adverse Perinatal Outcomes in Taiwan:
A Population-Based Birth Cohort Study. Int J Environ Res Public Health.
2020;17:1221.
-
Liu P, Xu L, Wang Y, et al. Association between perinatal outcomes and
maternal pre-pregnancy body mass index. Obes Rev 2016;17:1091-1102.
-
Masturzo B, Franzè V, Germano C, et al. Risk of Adverse Pregnancy
Outcomes by Pre-Pregnancy Body Mass Index among Italian Population:
A Retrospective Population-Based Cohort Study on 27,807 Deliveries. Arch
Gynecol Obstet. 2019;299:983-991.
-
Boutari C, Pappas PD, Mintziori G, et al. The Effect of Underweight on
Female and Male Reproduction. Metabolism. 2020;107:154229.
-
Balsells M, García-Patterson A, Corcoy R. Systematic review and meta-analysis
on the association of prepregnancy underweight and miscarriage. Eur
J Obstet Gynecol Reprod Biol. 2016; 207:73-79.
-
Hoellen F, Hornemann A, Haertel C, et al. Does maternal underweight prior to
conception influence pregnancy risks and outcome? In Vivo. 2014;28:1165-1170.
-
The Health Consequences of Smoking—50 Years of Progress. A Report of the
Surgeon General. National Center for Chronic Disease Prevention and Health
Promotion (US) Office on Smoking and Health. Atlanta (GA): Centers for
Disease Control and Prevention (US); 2014. Available at: https://www.ncbi.nlm.nih.gov/books/NBK179276/ (Accessed on 27 Oct 2022)
-
Lassi ZS, Imam AM, Dean SV, et al. Preconception care: caffeine, smoking,
alcohol, drugs and other environmental chemical/radiation exposure. Reprod
Health. 2014;11 Suppl 3(Suppl 3):S6.
-
American College of Obstetricians and Gynecologists. ACOG Committee
Opinion No. 691. Carrier screening for genetic conditions. Obstet Gynecol
2017;129:e41–e55.
-
Chan OYM, Leung TY, Cao Y, et al. Expanded carrier screening using next-generation
sequencing of 123 Hong Kong Chinese families: a pilot study.
Hong Kong Med J 2021;27:177–183.
Sue ST Lo,
MBBS, MD, FRCOG
Senior Doctor,
The Family Planning Association of Hong Kong
Correspondence to:
Dr. Sue ST Lo, The Family Planning Association of Hong Kong, 10/F,
130 Hennessy Road, Southorn Centre, Wan Chai, Hong Kong SAR.
E-mail: stlo@famplan.org.hk
|